2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Print

Poster Session

[P18] Poster Session 18　Hematologic Malignancies（Case Report）

[P18-3] Lenalidomide plus rituximab regimen for anti-CD20 monoclonal antibody refractory indolent lymphoma: 6 case series

○Rie Ito (Department of Hematology and Oncology, Toyohashi Municipal Hospital)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password